UFP Technologies, Inc. (UFPT) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
UFP Technologies, Inc. (UFPT) trades at $236.21 with AI Score 88/100 (Grade A+). UFP Technologies, Inc. specializes in designing and manufacturing custom components and packaging solutions, primarily for the medical market. Market cap: $1.83B, Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: May 10, 2026Analyst Coverage for UFPT: UFPT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates UFPT against Healthcare peers across nine fundamental dimensions and assigns a relatively strong fundamental profile based on the underlying data.
UFPT: 3/3 scored disciplines lean bullish. Dominant signal: Growth Durability strong.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
UFP Technologies, Inc. (UFPT) Healthcare & Pipeline Overview
UFP Technologies, Inc. (UFPT) is a custom manufacturer specializing in single-use medical devices and components, leveraging specialized foams, films, and plastics. With a strong foothold in the healthcare sector, the company also serves automotive, aerospace, and defense industries, distinguishing itself through custom solutions and a direct sales approach.
What Is the Investment Thesis for UFPT?
UFP Technologies, Inc. presents a compelling investment case driven by its strong position in the growing medical device component market. With a market capitalization of $1.83B and a P/E ratio of 25.94, the company demonstrates solid financial health. A key value driver is its focus on single-use medical devices, aligning with increasing healthcare demands for infection control and patient safety. Growth catalysts include expanding its product offerings in high-growth areas such as minimally invasive surgery and wearable medical devices. However, investors may want to evaluate potential risks, including competition from other materials manufacturers and dependence on key customer relationships. The company's ability to maintain its 11.3% profit margin and 28.4% gross margin will be crucial for sustained profitability.
Based on FMP financials and quantitative analysis
UFPT Key Highlights
- Market capitalization of $1.83B reflects investor confidence in UFPT's market position and growth potential.
- P/E ratio of 25.94 indicates a premium valuation, suggesting expectations of future earnings growth.
- Profit margin of 11.3% demonstrates efficient operations and pricing strategies.
- Gross margin of 28.4% highlights the value-added nature of UFPT's custom manufacturing capabilities.
- Beta of 1.17 suggests UFPT's stock price is slightly more volatile than the overall market.
Who Are UFPT's Competitors?
UFPT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LFTSF LifeTech Scientific Corporation | $0.23 | +0.00% | $2.00B | 63 |
| INSP Inspire Medical Systems, Inc. | $50.81 | +0.81% | $1.46B | 95 |
| TMDX TransMedics Group, Inc. | $71.13 | -0.10% | $2.46B | 80 |
| CNMD CONMED Corporation | $41.27 | -1.74% | $1.24B | 76 |
| AORT Artivion Inc. | $25.00 | -0.56% | $1.21B | 61 |
| IRMD IRadimed Corporation | $93.86 | -0.23% | $1.20B | 97 |
| SILK Silk Road Medical, Inc | $27.49 | -0.04% | $1.12B | 60 |
| ITGR Integer Holdings Corporation | $97.50 | +0.97% | $3.31B | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UFPT's Key Strengths?
- Strong position in the medical device component market.
- Expertise in custom manufacturing and specialized materials.
- Diversified customer base across multiple industries.
- Established long-term customer relationships.
What Are UFPT's Weaknesses?
- Dependence on direct sales force in the United States.
- Potential for fluctuations in raw material costs.
- Limited brand recognition compared to larger competitors.
- Exposure to regulatory changes in the medical device industry.
What Could Drive UFPT Stock Higher?
- Expansion of product offerings in high-growth areas such as minimally invasive surgery and wearable medical devices.
- Strategic partnerships with leading medical device manufacturers to secure long-term contracts.
- Potential acquisitions of smaller companies with complementary technologies or product lines.
- Continued investment in research and development to create innovative materials and solutions.
What Are the Key Risks for UFPT?
- Intense competition from other materials manufacturers.
- Fluctuations in raw material costs impacting profitability.
- Product liability claims related to medical device components.
- Economic downturns impacting demand in various industries.
- Regulatory changes in the medical device industry.
What Are the Growth Opportunities for UFPT?
- Expansion in Minimally Invasive Surgery Components: The market for minimally invasive surgery (MIS) is experiencing rapid growth due to reduced patient recovery times and lower healthcare costs. UFP Technologies can capitalize on this trend by developing and manufacturing specialized foam and plastic components for MIS devices. This market segment is projected to reach $36 billion by 2028, offering a substantial growth opportunity for UFPT. By leveraging its expertise in custom materials and design, UFPT can secure contracts with leading MIS device manufacturers.
- Penetration of the Wearable Medical Device Market: The wearable medical device market is expanding rapidly, driven by increasing consumer interest in remote patient monitoring and personalized healthcare. UFP Technologies can leverage its materials expertise to develop comfortable, biocompatible components for wearable sensors, drug delivery systems, and monitoring devices. The global wearable medical device market is expected to reach $29.6 billion by 2029, presenting a significant growth avenue for UFPT. Strategic partnerships with wearable device companies will be crucial for market penetration.
- Geographic Expansion into Emerging Markets: Expanding its sales and manufacturing presence in emerging markets, particularly in Asia-Pacific, represents a significant growth opportunity for UFP Technologies. The increasing healthcare spending and growing demand for advanced medical devices in these regions create a favorable environment for UFPT's products. Establishing strategic partnerships with local distributors and manufacturers will be essential for navigating regulatory hurdles and gaining market access. This expansion could increase revenue by 15% over the next five years.
- Development of Advanced Materials for Orthopedic Implants: The orthopedic implant market is continuously evolving, with a growing demand for advanced materials that enhance biocompatibility, durability, and patient comfort. UFP Technologies can invest in research and development to create innovative foam and plastic materials for orthopedic implants and soft goods. This includes exploring materials with improved antimicrobial properties and enhanced structural integrity. Successful development and commercialization of these materials could significantly boost UFPT's revenue and market share in the orthopedic sector.
- Strategic Acquisitions to Expand Product Portfolio: UFP Technologies can pursue strategic acquisitions of smaller companies with complementary technologies or product lines to expand its portfolio and market reach. This includes targeting companies specializing in advanced materials, medical device components, or packaging solutions. Acquisitions can provide UFPT with access to new technologies, customer relationships, and geographic markets, accelerating its growth trajectory. Careful due diligence and integration planning will be crucial for maximizing the value of these acquisitions.
What Opportunities Does UFPT Have?
- Expansion into new therapeutic areas within the medical market.
- Penetration of the wearable medical device market.
- Geographic expansion into emerging markets.
- Strategic acquisitions to expand product portfolio.
What Threats Does UFPT Face?
- Intense competition from other materials manufacturers.
- Potential for product liability claims.
- Economic downturns impacting demand in various industries.
- Disruptions in the supply chain for raw materials.
What Are UFPT's Competitive Advantages?
- Customization Capabilities: UFP Technologies' ability to design and manufacture custom components tailored to specific customer needs provides a competitive advantage.
- Material Expertise: The company's expertise in specialized foams, films, and plastics allows it to create unique and high-performance solutions.
- Long-Standing Customer Relationships: UFP Technologies has established long-term relationships with key customers across various industries, creating switching costs and repeat business.
- Diversified End Markets: Serving a diverse range of industries reduces the company's dependence on any single market, mitigating risk and providing stability.
What Does UFPT Do?
Founded in 1963 and headquartered in Newburyport, Massachusetts, UFP Technologies, Inc. has evolved into a leading designer and manufacturer of custom-engineered solutions utilizing specialized foams, films, and plastics. Initially serving various industrial sectors, the company strategically shifted its focus towards the medical market, now its primary revenue driver. UFP Technologies provides single-use and single-patient devices and components integral to medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. Beyond healthcare, UFP Technologies continues to serve the automotive, aerospace and defense, consumer, electronics, and industrial markets. These solutions range from military uniform and gear components and automotive interior trim to athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. The company markets and sells its products primarily through a direct sales force within the United States, supplemented by independent manufacturer representatives, ensuring close customer relationships and tailored solutions.
What Products and Services Does UFPT Offer?
- Designs and manufactures custom components for medical devices.
- Produces single-use and single-patient devices for the healthcare industry.
- Creates specialized packaging solutions for medical implants and instruments.
- Supplies engineered products for the automotive industry, including interior trim components.
- Provides protective components for military uniforms and gear.
- Offers custom solutions for the aerospace and defense sectors.
- Manufactures components for consumer products, such as athletic padding and protective cases.
- Develops specialized components for the electronics and industrial markets.
How Does UFPT Make Money?
- Custom Manufacturing: UFP Technologies generates revenue by designing and manufacturing custom components and products based on specific customer requirements.
- Direct Sales: The company primarily utilizes a direct sales force to market and sell its products within the United States, fostering close customer relationships.
- Diversified Markets: UFP Technologies serves a diverse range of industries, including medical, automotive, aerospace, defense, consumer, electronics, and industrial, mitigating risk through market diversification.
- Value-Added Solutions: The company focuses on providing value-added solutions through its expertise in specialized foams, films, and plastics, differentiating itself from competitors.
What Industry Does UFPT Operate In?
UFP Technologies operates within the medical device industry, a sector characterized by continuous innovation and stringent regulatory requirements. The market for medical device components is projected to grow, driven by an aging population, increasing prevalence of chronic diseases, and technological advancements in medical treatments. Competition is intense, with companies vying for market share through product differentiation and strategic partnerships. UFP Technologies distinguishes itself through its focus on custom manufacturing and its ability to provide specialized solutions for diverse medical applications. The company's expansion into high-growth areas such as minimally invasive surgery and wearable medical devices positions it favorably within the evolving healthcare landscape.
Who Are UFPT's Key Customers?
- Medical Device Manufacturers: Companies that produce medical devices and require custom components for their products.
- Automotive Companies: Manufacturers of automobiles that utilize UFP Technologies' products for interior trim and other applications.
- Aerospace and Defense Contractors: Companies that provide products and services to the aerospace and defense industries and require specialized components.
- Consumer Product Companies: Businesses that manufacture consumer products and require custom components for their goods.
F-Score 7/9Financial Health
UFP Technologies, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 7.23 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE 17%Key Financial Metrics
Return on equity for UFP Technologies, Inc. stands at 16.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.2%, showing how much profit it generates from its asset base. UFPT trades at a trailing price-to-earnings ratio of 26.58, above the Healthcare sector average of ~23x. Its free cash flow yield is 3.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.91 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.8%, the inverse of the P/E and a quick read on earnings relative to price.
UFP Technologies, Inc. (UFPT) Valuation Context
Valued at $1.83B, UFPT is classified as a small-cap stock. Relative to its peer group, UFPT's quantitative score of 88/100 is above the peer average of 75/100.
FY2026 estForward Outlook
Wall Street analysts project UFP Technologies, Inc. revenue of about $640.0M for fiscal 2026, with EPS near $9.50. The estimate reflects 3 contributing analysts.
UFPT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong position in the medical device component market.
- Expertise in custom manufacturing and specialized materials.
- Diversified customer base across multiple industries.
- Established long-term customer relationships.
Bear Case
- Dependence on direct sales force in the United States.
- Potential for fluctuations in raw material costs.
- Limited brand recognition compared to larger competitors.
- Exposure to regulatory changes in the medical device industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
UFPT Latest News
-
Earnings Scheduled For May 4, 2026
benzinga · May 4, 2026
-
Earnings Scheduled For February 24, 2026
benzinga · Feb 24, 2026
-
Stocks That Hit 52-Week Highs On Tuesday
· Feb 11, 2020
-
Stocks That Hit 52-Week Highs On Tuesday
· Nov 26, 2019
UFPT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for UFPT.
Price Targets
Wall Street price target analysis for UFPT.
UFPT MoonshotScore
What does this score mean?
The MoonshotScore rates UFPT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: R. Jeffrey Bailly
CEO
R. Jeffrey Bailly serves as the Chief Executive Officer of UFP Technologies, Inc. His career spans several decades in the manufacturing and engineering sectors. He has a proven track record in strategic leadership, operational excellence, and driving profitable growth. Bailly's expertise lies in developing and implementing innovative solutions to meet customer needs and navigating complex market dynamics. His experience includes roles in various leadership positions, providing him with a comprehensive understanding of the industry landscape.
Track Record: Under R. Jeffrey Bailly's leadership, UFP Technologies has strengthened its position in the medical device component market and expanded its presence in other key industries. He has overseen strategic investments in research and development, resulting in the development of innovative materials and solutions. Bailly has also focused on enhancing operational efficiency and fostering a culture of continuous improvement. His leadership has contributed to the company's sustained profitability and growth.
What Investors Ask About UFP Technologies, Inc. (UFPT) — Healthcare
What does the AI Score mean for UFPT?
UFPT holds an AI Score of 88/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. UFP Technologies, Inc. specializes in designing and manufacturing custom components and packaging solutions, primarily for the medical market. The company leverages specialized foams, films, …
What does UFP Technologies, Inc. do?
UFP Technologies, Inc. specializes in the design and custom manufacturing of components, subassemblies, products, and packaging, primarily utilizing specialized foams, films, and plastics. The company focuses on the medical market, providing single-use and single-patient devices and components used in various medical applications, including wound care, infection prevention, minimally invasive surgery, and orthopedic implant packaging.
What do analysts say about UFPT stock?
Analyst coverage of UFP Technologies, Inc. (UFPT) reflects a generally positive outlook, driven by the company's strong position in the medical device component market and its diversified customer base. Key valuation metrics, such as the P/E ratio of 25.94, suggest that investors anticipate continued earnings growth.
What are the main risks for UFPT?
UFP Technologies, Inc. faces several risks inherent to its industry and business model. Intense competition from other materials manufacturers could put pressure on pricing and margins. Fluctuations in raw material costs, particularly for specialized foams, films, and plastics, could impact profitability. Product liability claims related to medical device components pose a potential financial risk.
What are the key factors to evaluate for UFPT?
UFP Technologies, Inc. (UFPT) holds an AI score of 88/100 (high). Not financial advice.
How frequently does UFPT data refresh on this page?
UFPT's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven UFPT's recent stock price performance?
UFP Technologies, Inc. (UFPT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong position in the medical device component market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UFPT overvalued or undervalued right now?
UFP Technologies, Inc. (UFPT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research UFPT before investing?
Before investing in UFP Technologies, Inc. (UFPT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- Financial data is as of 2026-05-10.